Cite

    Ruperto, N. et al. (2010). Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Annals of the rheumatic diseases. 69 (4), pp. 718-722. [Online].